Videssa® Breast: Cancer Blood Test
LymPro™: Alzheimer's Blood Test
TolloTest™: Coronavirus 3CL Protease Test
TBIA: AI Cancer Platform
Antiviral Drug Development
Tollovir™: 3CL Protease Inhibitor
Products & Services
Provista Diagnostics: CLIA/CAP Lab
COVID Testing: Lab Supplies & Automated Solutions
Tollovid™: 3CL Protease Inhibitor
News & Media
How It Works: 3CL Protease Inhibitors
Case Study: Lab Automation
Board of Directors
Add a button link here
R&D Pipeline: Proprietary Diagnostics
Breakthroughs Coming in the R&D Pipeline
Blood based tests are the future of diagnostics screening.
Our TBIA platform represents a cost effective, scalable, and patient friendly screening method for cancer detection.
A cancer blood test designed specifically for the early detection of breast cancer in women with abnormal imaging findings
Validated blood-based assay for differentiating between non-AD Dementia / Prodromal AD / MCI / Alzheimer’s Disease
Diagnostic coronavirus test that measures 3CL protease from upper respiratory samples
An AI Platform reading the Immune Response to Cancer
Stay informed of our latest breakthroughs.
Team Member Name
Team member bio information.